CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd

BSE 544222 AKUMS INE09XN01023
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

12 filings · 2 material · busiest 2026-08-10

What it files

Analyst / Investor Meet6 General3 Concall Transcript1 Board Meeting1 Acquisition1

Filings

12 in the window

  1. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet

    Company Update / Analyst / Investor Meet View filing →

  2. 24 August 2026

    General

    Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026

    Akums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026

    Company Update / General View filing →

  3. 13 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27

    Company Update / Earnings Call Transcript View filing →

  4. 13 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet

    Company Update / Analyst / Investor Meet View filing →

  5. 10 August 2026

    General

    Monitoring Agency Report

    Monitoring Agency Report for the quarter ended June 30, 2026

    Company Update / General View filing →

  6. 10 August 2026

    General

    Newspaper Publication

    Newspaper Publication

    Company Update / General View filing →

  7. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Link of audio recording of Investors/Analysts Conference Call

    Company Update / Analyst / Investor Meet View filing →

  8. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Investors/Analysts Meet to be held on August 14, 2026

    Company Update / Analyst / Investor Meet View filing →

  9. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 30Th June, 2026

    Akums Drugs And Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve the un-audited ....

    Board Meeting / Board Meeting View filing →

  10. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27

    Company Update / Analyst / Investor Meet View filing →

  11. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27

    Company Update / Analyst / Investor Meet View filing →

  12. 23 July 2026

    Acquisition

    Acquisition

    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Acquisition of Oriflame India's Manufacturing Business

    Company Update / Acquisition View filing →